All news (page 21)

• 

  27 February 2026

  Ercros Reports EUR 8M EBITDA, EUR 54M Loss

  Weak demand, high energy costs, and competition impact results. Cost reduction plan on track. Financial debt reduced. Takeover bid rejected. Demand recovery expected in late 2026.
• 

  27 February 2026

  Neste Board Nominee Withdraws from 2026 AGM Election

  Simo Sääskilahti withdraws from Board election. The Board will have eight members. Remaining candidates are proposed for election.
• 

  27 February 2026

  BASF Advances "Winning Ways" Strategy Milestones

  BASF boosts free cash flow, starts Zhanjiang plants, and cuts costs. 2025 EBITDA drops to €6.6B; 2026 outlook: €6.2-7.0B EBITDA, €1.5-2.3B free cash flow.
• 

  26 February 2026

  GSK's Bepirovirsen Under Review in Japan for Chronic Hepatitis B Treatment

  Japan reviews bepirovirsen for chronic hepatitis B. Phase III trials show higher functional cure rates and acceptable safety. SENKU designation granted for expedited review.
• 

  26 February 2026

  GSK's Linerixibat Gets Priority Review in China for PBC-Related Itch

  Linerixibat shows significant improvement in cholestatic pruritus in PBC patients, based on GLISTEN phase III trial data. Regulatory reviews ongoing in US, EU, UK, and Canada.
• 

  26 February 2026

  thyssenkrupp Automotive Body Solutions Joins IPAI for Smart Manufacturing Innovation

  The company joins IPAI to integrate AI in manufacturing, enhancing robotics and expanding globally, with a focus on intelligent production and quality monitoring.

• 

  26 February 2026

  Indaver to Acquire Medway Energy Centre from Low Carbon

  Indaver plans to expand waste treatment in SE England, generating low-carbon electricity. The project aligns with their UK strategy and complements Low Carbon's development efforts.
• 

  26 February 2026

  Grupa Azoty Introduces New Sulphur-Containing Fertilizer

  The new product strengthens the fertilizer segment, supporting stable growth and competition in Europe while enhancing food security in Poland and the region.
• 

  26 February 2026

  MOL Accuses JANAF of Legal Violations Over Russian Oil Transit

  MOL demands JANAF allow unsanctioned Russian oil via sea, citing EU/US rules. Non-compliance may lead to legal action and claims for damages.
• 

  26 February 2026

  PureCycle Technologies Q4 2025 Results and Update

  Record production, revenue growth, expansion in Thailand and Belgium, and leadership changes. Gen-2 design shows cost efficiency. Financials stable with ongoing projects and debt management.
• 

  26 February 2026

  TotalEnergies to Export 2 Mtpa LNG from Alaska Project for 20 Years

  The Alaska LNG project, with a 20 Mtpa capacity, aims to supply Asia, enhancing energy security and transpacific ties. It has strong U.S. support and offers logistical advantages.
• 

  26 February 2026

  Asahi Kasei Acquires Aicuris for €780 Million

  The acquisition enhances Asahi Kasei's pharmaceutical platform in severe infectious diseases, leveraging existing infrastructure for growth and expanding its treatment portfolio.
• 

  26 February 2026

  FDA Approves Boehringer Ingelheim's HERNEXEOS for HER2-Mutant NSCLC

  HERNEXEOS gains FDA approval for HER2-mutant NSCLC, showing a 76% response rate in trials. Further confirmation required for continued approval.
• 

  26 February 2026

  Uniper's CCO Carsten Poppinga to Depart

  Poppinga to join EnBW as Head of Trading post-cooling period. CEO Michael Lewis to cover CCO duties until a successor is named.
• 

  26 February 2026

  Technip Energies Nominates John O’Higgins and Luc Rémont for Board Positions

  Joseph Rinaldi to retire in 2026. John O’Higgins and Luc Rémont nominated as Board Observers, pending shareholder approval for Non-Executive Director roles.
• 

  26 February 2026

  Johnson & Johnson Reports Positive Early Results for Pasritamig and Docetaxel in Prostate Cancer

  Phase 1b study shows pasritamig and docetaxel combo is safe and effective in prostate cancer, with high PSA response rates, supporting Phase 3 trials.
• 

  26 February 2026

  BASF Introduces Biomass Balance Autofroth Foam for North American Market

  BMB Autofroth foam cuts carbon emissions by 18-20%, offers a drop-in solution for sustainability without process changes, and suits various applications.
• 

  26 February 2026

  BASF Appoints Thomas Biegi for Communications and Government Relations

  Thomas Biegi, with a strong background in pharma and biotech communications, will succeed Nina Schwab-Hautzinger in April 2026, reporting to Markus Kamieth.
• 

  26 February 2026

  Lilly's Orforglipron Outperforms Semaglutide in Diabetes Trial

  Orforglipron 36 mg reduced A1C by 2.2% and weight by 9.2%, surpassing semaglutide in a 52-week trial with 1,698 participants. Results published in The Lancet.
• 

  26 February 2026

  Aramco Advances Gas Expansion with Jafurah and Tanajib Projects

  Jafurah and Tanajib projects boost gas production, aiming for 80% capacity increase by 2030, supporting economic growth and energy diversification.
• 

  26 February 2026

  Boehringer Ingelheim Licenses Immune Disease Program from Sitryx

  Boehringer gains exclusive rights to Sitryx's preclinical program for autoimmune diseases, with potential payments over $500M and tiered royalties on future sales.
• 

  26 February 2026

  Veolia Expands in India with Major Mumbai Water Projects

  Secures 15-year contracts for Mumbai's largest water plants, enhancing water security and efficiency with advanced tech, aiming to double India's revenues by 2030.
• 

  26 February 2026

  Veolia 2025 Results Overview

  Strong 2025 results with growth in international markets, early ROCE target achievement, key acquisitions, increased dividend, and positive 2026 outlook.
• 

  26 February 2026

  Veolia Secures £1bn UK Waste Management Contracts for 2025

  11 new contracts with UK local authorities boost Veolia's municipal services by 35%, supporting decarbonisation and resource preservation.
• 

  26 February 2026

  Eni Reports Strong 2025 Financial and Strategic Progress

  Strong Q4 results with 35% net income growth. Major projects launched, production up 7%. LNG expansion, biofuels growth, and strategic partnerships enhance resilience and shareholder returns.
• 

  26 February 2026

  Clariant Achieves Third Year of EBITDA Margin Growth

  Q4 2025 sales rose 1% in local currencies. FY 2025 EBITDA margin up 180 basis points to 17.8%. Performance programs saved CHF 50M. 2026 sales expected flat; EBITDA margin around 18%.
• 

  26 February 2026

  Covestro Meets 2025 Guidance Amid Challenges

  Sales and EBITDA fell in 2025. Strategic moves and partnerships aim to boost growth. 2026 outlook: stable EBITDA, improved cash flow, and reduced emissions.
• 

  26 February 2026

  Technip Energies 2025 Financial Results

  Strong 2025 results with revenue and EBITDA growth, dividend increase, share buyback, and strategic acquisition. Positive outlook for 2026 with robust backlog and sustainability focus.
• 

  26 February 2026

  2025 Results: Arkema Performance Summary

  Strong cash flow and EBITDA, sales growth in key markets, successful capacity expansions, and sustainability progress. Dividend stable; 2026 targets slight EBITDA growth amid weak demand.
• 

  26 February 2026

  EEW Advances Flue Gas Cleaning Modernization in Helmstedt

  EEW invests in flue gas cleaning to meet strict emissions, enhance environmental performance, and ensure long-term site viability during ongoing operations in Helmstedt.